IP Verse

Syringe - EP3381444B1

PatentPatent Analysis

EP3381444

NOVARTIS
Application Number
EP18162017A
Filing Date
Jan 25, 2013
Status
Granted And Under Opposition
Apr 16, 2021
Grant Date
May 19, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Bibliography

The patent EP3381444B1 was granted to Novartis on May 19, 2021 following the initial filing on Jan 25, 2013 under the application number EP18162017A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSApr 28, 2023INTERVENTION ADMISSIBLE
HAMM & WITTKOPPFeb 21, 2022WITHDRAWN
HOFFMANN EITLEFeb 18, 2022WITHDRAWN
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBFeb 17, 2022WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents